| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.15B | +21.2% |
| Cost of Revenue | $205.6M | +17.9% |
| Gross Profit | $946.1M | +22.0% |
| R&D Expense | $313.0M | +4.1% |
| SG&A Expense | $217.5M | +11.1% |
| Operating Income | -$136.4M | +36.7% |
| Pre-tax Income | -$104.2M | +44.7% |
| Income Tax | $1.8M | +39.4% |
| Net Income | -$106.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $437.7M | +22.3% |
| Short-term Investments | $337.7M | +5.5% |
| Accounts Receivable | $246.5M | +19.3% |
| Current Assets | $1.10B | +15.1% |
| Total Assets | $2.10B | +11.0% |
| Current Liabilities | $728.0M | +13.3% |
| Total Liabilities | $813.0M | +10.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $196.2M | +113.2% |
| Capital Expenditures | $19.1M | +85.4% |
| Investing Cash Flow | -$150.1M | -97.4% |
| Financing Cash Flow | $36.2M | -12.0% |
| Free Cash Flow | $177.0M | +116.7% |
| +44.1% |
| EPS (Basic) | -$0.72 | +46.3% |
| EPS (Diluted) | -$0.72 | +46.3% |
| Stockholders' Equity |
| $1.29B |
| +11.5% |